Jan.2024, LBMM has been awarded with a BRIDGE Proof-of-Concept grant!
© 2024 EPFL
The lab has been very active in the field of antibody discovery for more than a decade, and hence it is time for droplet microfluidic antibody discovery 2.0.
The new project focusses on highly multiplexed assays, using transcriptomic readouts as an indicator for cellular function. The project has been awarded with a BRIDGE grant, having a volume of 784k CHF.